Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Terminated NCT06470815

ROADSTER 3 Extended Follow-up Sub-Study

Conditions: Carotid Artery Diseases

Sex: All

Ages: 18 Years – 79 Years

Healthy volunteers: No

Enrollment: 197

Sponsor: Silk Road Medical

Location: Valley Vascular Consultants Huntsville Alabama

Summary

The study objective is to evaluate long-term outcomes for participants enrolled in the ROADSTER 3 study and treated with the ENROUTE Transcarotid Stent System (TSS) and ENROUTE Transcarotid Neuroprotection System (NPS).

Eligibility Criteria

Inclusion Criteria: * Participants who were enrolled in the ROADSTER 3 study and treated with the ENROUTE TSS and ENROUTE NPS * Able to provide informed consent Exclusion Criteria: * Participants who have exited the ROADSTER 3 study early (i.e., prior to completion of protocol required follow-up) will not participate in the sub-study

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06470815). StuddyBuddy aggregates publicly available trial information.